36 clinical trials
grid
list
download
| Body (indexed field) | Identifiant (ID) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 22819 | Available tumor tissue | Martine Piccart | Multiple | Institut Jules Bordet | PRECISION | Trial closed | The Jules Bordet Institute Program for Molecular Profiling of Metastatic Lesions : Feasibility | martine.piccart@hubruxelles.be | |||
| 22726 | Rectal adenocarcinoma requiring preoperative radiotherapy | Alain Hendlisz | Rectum | GHdC | R-IMMUNE | Trial closed for recruitment | A Phase IB/II study to evaluate safety and efficacy of Atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer (R-IMMUNE). | alain.hendlisz@hubruxelles.be | 1b | 1 | |
| 28772 | Alain Hendlisz | Multiple | Institut Jules Bordet | REGINA | Trial open for recruitment | A phase II trial of neoadjuvant REGorafenib in combination with nIvolumab and short-course radiotherapy iN intermediate-risk, stage II-III rectAl cancer | alain.hendlisz@hubruxelles.be | 2 | 2 | ||
| 22848 | Smoker of quit smoking within the last 6 months, any tumors | Solid tumors | Institut Jules Bordet | Sevrage Tabagique | Trial open for recruitment | Impact of an emotion and craving regulation intervention on smoking cessation and maintenance among oncology patients : a randomized study | |||||
| 29767 | Saude Conde Rita | Rectum | Bordet | SHAPERS | Trial open for recruitment | Efficacy and safety of short-course radiotherapy (SCRT) versus total neoadjuvant therapy in older patients with locally advanced rectal cancer: a multicentre, open-label, randomised pragmatic clinical trial | 3 | 3 | |||
| 22641 | Biopsy mandatory, neoadjuvant | Alain Hendlisz | Colon | Celyad | SHRINK | Trial closed for recruitment | CELYAD SHRINK : An open-label, Phase I study to assess the safety and clinical activity of multiple doses of NKR-2, administered concurrently with the neoadjuvant Folfox treatment in patients with potentially resectable liver metastases from colorectal cancer | alain.hendlisz@hubruxelles.be | 1 | 1 | |
| 22617 | CRC, UICC stage IV or high risk stage III independently of the pretreatment received. | Alain Hendlisz | Colon | EORTC | SPECTAcolor | Trial closed | SPECTAcolor - Screening platform of the EORTC for Clinical Trials in Advanced Colorectal cancer | alain.hendlisz@hubruxelles.be | |||
| 23023 | RECIST v1.1 | Philippe Aftimos | Multiple | Synthon Biopharmaceuticals | SYD985.004 | Trial closed for recruitment | A two-part phase I study with the antibody-drug conjugate SYD985 in combination with niraparib to evaluate safety, pharmacokinetics and efficacy in patients with HER2-expressing locally advanced or metastatic solid tumours | philippe.aftimos@hubruxelles.be | 1 | 1 |